250 related articles for article (PubMed ID: 29628444)
1. PH domain leucine-rich repeat protein phosphatase 2 (PHLPP2) regulates G-protein-coupled receptor kinase 5 (GRK5)-induced cardiac hypertrophy
Yeh ST; Zambrano CM; Koch WJ; Purcell NH
J Biol Chem; 2018 May; 293(21):8056-8064. PubMed ID: 29628444
[TBL] [Abstract][Full Text] [Related]
2. Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication.
Gold JI; Gao E; Shang X; Premont RT; Koch WJ
Circ Res; 2012 Sep; 111(8):1048-53. PubMed ID: 22859683
[TBL] [Abstract][Full Text] [Related]
3. GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity.
Hullmann JE; Grisanti LA; Makarewich CA; Gao E; Gold JI; Chuprun JK; Tilley DG; Houser SR; Koch WJ
Circ Res; 2014 Dec; 115(12):976-85. PubMed ID: 25332207
[TBL] [Abstract][Full Text] [Related]
4. Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy.
Traynham CJ; Cannavo A; Zhou Y; Vouga AG; Woodall BP; Hullmann J; Ibetti J; Gold JI; Chuprun JK; Gao E; Koch WJ
Circ Res; 2015 Dec; 117(12):1001-12. PubMed ID: 26515328
[TBL] [Abstract][Full Text] [Related]
5. CaMKIIδ meditates phenylephrine induced cardiomyocyte hypertrophy through store-operated Ca
Ji Y; Guo X; Zhang Z; Huang Z; Zhu J; Chen QH; Gui L
Cardiovasc Pathol; 2017; 27():9-17. PubMed ID: 27940402
[TBL] [Abstract][Full Text] [Related]
6. Regulation of nuclear factor κB (NF-κB) in the nucleus of cardiomyocytes by G protein-coupled receptor kinase 5 (GRK5).
Islam KN; Bae JW; Gao E; Koch WJ
J Biol Chem; 2013 Dec; 288(50):35683-9. PubMed ID: 24174526
[TBL] [Abstract][Full Text] [Related]
7. The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors.
Sorriento D; Santulli G; Ciccarelli M; Maione AS; Illario M; Trimarco B; Iaccarino G
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543709
[TBL] [Abstract][Full Text] [Related]
8. A novel role of G protein-coupled receptor kinase 5 in urotensin II-stimulated cellular hypertrophy in H9c2
Park CH; Lee JH; Lee MY; Lee JH; Lee BH; Oh KS
Mol Cell Biochem; 2016 Nov; 422(1-2):151-160. PubMed ID: 27613164
[TBL] [Abstract][Full Text] [Related]
9. Nuclear translocation of cardiac G protein-Coupled Receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process.
Gold JI; Martini JS; Hullmann J; Gao E; Chuprun JK; Lee L; Tilley DG; Rabinowitz JE; Bossuyt J; Bers DM; Koch WJ
PLoS One; 2013; 8(3):e57324. PubMed ID: 23472081
[TBL] [Abstract][Full Text] [Related]
10. PHLPP2 downregulation protects cardiomyocytes against hypoxia-induced injury through reinforcing Nrf2/ARE antioxidant signaling.
Jin A; Li B; Li W; Xiao D
Chem Biol Interact; 2019 Dec; 314():108848. PubMed ID: 31610156
[TBL] [Abstract][Full Text] [Related]
11. A peptide of the N terminus of GRK5 attenuates pressure-overload hypertrophy and heart failure.
Coleman RC; Eguchi A; Lieu M; Roy R; Barr EW; Ibetti J; Lucchese AM; Peluzzo AM; Gresham K; Chuprun JK; Koch WJ
Sci Signal; 2021 Mar; 14(676):. PubMed ID: 33785612
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
[TBL] [Abstract][Full Text] [Related]
14. Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.
Slone S; Anthony SR; Wu X; Benoit JB; Aube J; Xu L; Tranter M
Cell Signal; 2016 Nov; 28(11):1735-41. PubMed ID: 27521603
[TBL] [Abstract][Full Text] [Related]
15. STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy.
Zhang X; Li W; Shen P; Feng X; Yue Z; Lu J; You J; Li J; Gao H; Fang S; Li Z; Liu P
J Cardiovasc Pharmacol; 2016 Sep; 68(3):204-14. PubMed ID: 27124607
[TBL] [Abstract][Full Text] [Related]
16. Activation of PH-domain leucine-rich protein phosphatase 2 (PHLPP2) by agonist stimulation in cardiac myocytes expressing adenylyl cyclase type 6.
Gao MH; Miyanohara A; Feramisco JR; Tang T
Biochem Biophys Res Commun; 2009 Jun; 384(2):193-8. PubMed ID: 19450723
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition.
Maning J; McCrink KA; Pollard CM; Desimine VL; Ghandour J; Perez A; Cora N; Ferraino KE; Parker BM; Brill AR; Aukszi B; Lymperopoulos A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326036
[TBL] [Abstract][Full Text] [Related]
18. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
Dong B; Xue R; Sun Y; Dong Y; Liu C
Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
[TBL] [Abstract][Full Text] [Related]
19. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes.
Martini JS; Raake P; Vinge LE; DeGeorge BR; Chuprun JK; Harris DM; Gao E; Eckhart AD; Pitcher JA; Koch WJ
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12457-62. PubMed ID: 18711143
[TBL] [Abstract][Full Text] [Related]
20. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER.
Goncalves GK; Scalzo S; Alves AP; Agero U; Guatimosim S; Reis AM
Am J Physiol Cell Physiol; 2018 Mar; 314(3):C310-C322. PubMed ID: 29167148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
